Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dbco-PEG4-VC-PAB-MMAE | 2129164-91-4 | 99.2% | 1658.03 | C88H128N12O19 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY136314100MG

Encompass_Preferred

DBCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate combining a DBCO click handle, a PEG4 spacer, a valine-citrulline-p-aminobenzyl cleavable linker, and the cytotoxic monomethyl auristatin E payload. It is intended for research use in synthesizing antibody-drug conjugates via strain-promoted alkyne-azide cycloaddition.

  • Used for strain-promoted alkyne-azide cycloaddition (SPAAC) conjugation.
  • Contains a PEG4 spacer for increased hydrophilicity.
  • Includes a valine-citrulline-p-aminobenzyl cleavable linker for intracellular release.
  • Incorporates monomethyl auristatin E as the cytotoxic payload.
  • High purity (99.18%).
  • Soluble in DMSO at 150 mg/mL; may require ultrasonic assistance.
  • Supplied as a powder; unstable in solution, store at -20°C and prepare fresh solutions.

Catalog No. 50-002-04182


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.